Subsequently, Wu et al. reported that the lncRNA IDH1-AS1 can regulate the IDH1–α-KG–HIF1a signaling axis and inhibit glycolysis in HCC cells by activating IDH1, thereby inhibiting the growth of tumor cells [6]. The gene discussed is IDH1; the disease is neoplasm.